Why was smallpox eradicated but not measles?

Why We Beat Smallpox But Not Measles

Smallpox, once one of humanity’s most feared diseases, was officially eradicated in ains 1980—a historic achievement in public health. Measles, despite having an effective vaccine, still circulates in many parts of the world. So why did we conquer one but not the other?

The answer lies in several key differences between the two viruses and the challenges they present. Smallpox had distinct advantages that made eradication feasible. For one, it only infected humans—there was no animal reservoir to reintroduce the virus. Infected individuals were clearly identifiable by their severe rash, making surveillance and containment much more effective. Plus, the smallpox vaccine was highly effective and provided long-lasting immunity after just one dose.

Measles, on the other hand, is far more contagious. In fact, it’s one of the most infectious viruses known—one person can spread it to 12 to 18 others in a susceptible population. This means that to stop transmission, we need over 95% vaccine coverage with two doses. Even small drops in vaccination rates can lead to outbreaks.

Another hurdle is that measles can spread before symptoms appear, making containment harder. Unlike smallpox, where people were visibly ill and easier to isolate, measles silently moves through communities. Plus, vaccine hesitancy, misinformation, and unequal access to healthcare have hampered global efforts to reach the necessary immunity threshold.

While measles eradication is technically possible, it demands stronger, more consistent global coordination than we’ve achieved so far. The tools are there—the vaccine is safe and effective—but the challenge lies in delivery, trust, and political will. Until we close those gaps, measles will remain one step ahead.